By Joe Hoppe

Barclays PLC said Monday that Chief Executive Officer C.S. Venkatakrishnan has been diagnosed with non-Hodgkin lymphoma, with treatment expected to last 12 to 16 weeks.

The FTSE 100-listed bank said the cancer has been detected early and the prognosis is good. Mr. Venkatakrishnan will continue to actively manage the company during the treatment period.

Write to Joe Hoppe at joseph.hoppe@wsj.com

(END) Dow Jones Newswires

November 28, 2022 04:52 ET (09:52 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Barclays (NYSE:BCS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Barclays Charts.
Barclays (NYSE:BCS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Barclays Charts.